6505--PET Prostate-Specific Membrane Antigen Radiopharmaceuticals Amend for Questions and Answers

Description

{"description":"\n PET Prostate-Specific Membrane Antigen (PSMA) Radiopharmaceuticals\n36C25226Q0211\n\nQuestions & Answers\n\nWill the awarded contractor assume all responsibility and accountability for providing contingency plans, prior to the award, to include alternative sources, in advance of any event in which local radio pharmacies are unable to provide routine delivery of Prostate Specific Membrane Antigen (PSMA) diagnostic imaging products?\nYes, the awarded contractor will be expected to assume full responsibility and accountability for providing contingency plans prior to the award. \n\nTypically, PSMA patients require flexibility in scheduling daily appointments. What is the specific requirement to provide PSMA for afternoon deliveries on the same day? \nAll orders will be placed ahead of time as part of routine scheduling. In the event of a same-day order for an afternoon delivery, the order will be submitted before 10:00 AM (or another mutually agreed-upon cut-off time) to allow sufficient time for dose preparation and delivery logistics.\n\nThere are currently, multiple FDA approved PSMA products available. Is this RFQ a Sole Source request? RFQ is not a Sole Source.\nSubject Line: \"PET Prostate-Specific Membrane Antigen (PSMA) Radiopharmaceuticals\"-\nfluciclovine F 18 (Axumin)\ngallium-68 PSMA-11 (Illuccix, Locametz)\nfluorine 18 (F 18) labeled agents piflufolastat F 18 (Pylarify)\nflotufolastat F 18 (Posluma)\n\n"} Solicitation Number: 36C25226Q0211 Type: Combined Synopsis/Solicitation Base Type: Combined Synopsis/Solicitation NAICS: 325412 Classification Code: 6505 Response Deadline: 2026-01-26T17:00:00-05:00 Office Address: MILWAUKEE, WI Place of Performance: Chicago, Illinois, 606412 POC: Stacy Massey, Stacy.Massey@va.gov, 4148448400 {"description":"\n PET Prostate-Specific Membrane Antigen (PSMA) Radiopharmaceuticals\n36C25226Q0211\n\nQuestions & Answers\n\nWill the awarded contractor assume all responsibility and accountability for providing contingency plans, prior to the award, to include alternative sources, in advance of any event in which local radio pharmacies are unable to provide routine delivery of Prostate Specific Membrane Antigen (PSMA) diagnostic imaging products?\nYes, the awarded contractor will be expected to assume full responsibility and accountability for providing contingency plans prior to the award. \n\nTypically, PSMA patients require flexibility in scheduling daily appointments. What is the specific requirement to provide PSMA for afternoon deliveries on the same day? \nAll orders will be placed ahead of time as part of routine scheduling. In the event of a same-day order for an afternoon delivery, the order will be submitted before 10:00 AM (or another mutually agreed-upon cut-off time) to allow sufficient time for dose preparation and delivery logistics.\n\nThere are currently, multiple FDA approved PSMA products available. Is this RFQ a Sole Source request? RFQ is not a Sole Source.\nSubject Line: \"PET Prostate-Specific Membrane Antigen (PSMA) Radiopharmaceuticals\"-\nfluciclovine F 18 (Axumin)\ngallium-68 PSMA-11 (Illuccix, Locametz)\nfluorine 18 (F 18) labeled agents piflufolastat F 18 (Pylarify)\nflotufolastat F 18 (Posluma)\n\n"}